Metlife Inc. buy piccolo90
Summary
This prediction ended on 09.11.16 with a price of €44.95. The BUY prediction by piccolo90 finished with a performance of 18.60%. piccolo90 has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Metlife Inc. | 2.924% | 2.924% | 16.056% | 50.095% |
| iShares Core DAX® | -0,22 % | 1,75 % | 2,66 % | 57,51 % |
| iShares Nasdaq 100 | -2,35 % | 0,22 % | 32,49 % | 88,48 % |
| iShares Nikkei 225® | -3,10 % | 2,93 % | 56,98 % | 75,66 % |
| iShares S&P 500 | -0,50 % | 1,99 % | 24,47 % | 68,57 % |
Comments by piccolo90 for this prediction
In the thread Metlife Inc. diskutieren
piccolo90 stimmt der Outperform-Einschätzung der institutionellen Analysten zu
piccolo90 stimmt am 14.07.2016 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 49.29$ zu.


